Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.

Abdul-Ghani R, Mahdy MA, Saif-Ali R, Alkubati SA, Alqubaty AR, Al-Mikhlafy AA, Al-Eryani SM, Al-Mekhlafi AM, Alhaj A.

Malar J. 2016 Jun 21;15:327. doi: 10.1186/s12936-016-1372-9.


How important is gametocyte clearance after malaria therapy?

Karunajeewa HA, Mueller I.

BMC Med. 2016 Jun 18;14:93. doi: 10.1186/s12916-016-0641-3.


The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.

Ehrhardt K, Deregnaucourt C, Goetz AA, Tzanova T, Gallo V, Arese P, Pradines B, Adjalley SH, Bagrel D, Blandin S, Lanzer M, Davioud-Charvet E.

Antimicrob Agents Chemother. 2016 Sep;60(9):5146-58. doi: 10.1128/AAC.02975-15.


Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda.

Chang HH, Meibalan E, Zelin J, Daniels R, Eziefula AC, Meyer EC, Tadesse F, Grignard L, Joice RC, Drakeley C, Wirth DF, Volkman SK, Buckee C, Bousema T, Marti M.

Sci Rep. 2016 May 20;6:26330. doi: 10.1038/srep26330.


Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.

Krause A, Dingemanse J, Mathis A, Marquart L, Möhrle JJ, McCarthy JS.

Br J Clin Pharmacol. 2016 Aug;82(2):412-21. doi: 10.1111/bcp.12962.


Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen.

Ahyong V, Sheridan CM, Leon KE, Witchley JN, Diep J, DeRisi JL.

Malar J. 2016 Mar 17;15:173. doi: 10.1186/s12936-016-1231-8.


Integrating Transgenic Vector Manipulation with Clinical Interventions to Manage Vector-Borne Diseases.

Okamoto KW, Gould F, Lloyd AL.

PLoS Comput Biol. 2016 Mar 10;12(3):e1004695. doi: 10.1371/journal.pcbi.1004695.


Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?

Hemingway J, Shretta R, Wells TN, Bell D, Djimdé AA, Achee N, Qi G.

PLoS Biol. 2016 Mar 2;14(3):e1002380. doi: 10.1371/journal.pbio.1002380. Review.


Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach.

Canavati SE, Lawford HL, Fatunmbi BS, Lek D, Top-Samphor N, Leang R, Dondorp AM, Huy R, Kazadi WM.

Malar J. 2016 Feb 25;15:120. doi: 10.1186/s12936-016-1117-9.


Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.

Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR.

Malar J. 2016 Feb 11;15:82. doi: 10.1186/s12936-016-1140-x.


Prevention of Malaria Resurgence in Greece through the Association of Mass Drug Administration (MDA) to Immigrants from Malaria-Endemic Regions and Standard Control Measures.

Tseroni M, Baka A, Kapizioni C, Snounou G, Tsiodras S, Charvalakou M, Georgitsou M, Panoutsakou M, Psinaki I, Tsoromokou M, Karakitsos G, Pervanidou D, Vakali A, Mouchtouri V, Georgakopoulou T, Mamuris Z, Papadopoulos N, Koliopoulos G, Badieritakis E, Diamantopoulos V, Tsakris A, Kremastinou J, Hadjichristodoulou C; MALWEST Project..

PLoS Negl Trop Dis. 2015 Nov 19;9(11):e0004215. doi: 10.1371/journal.pntd.0004215.


Bilayer Effects of Antimalarial Compounds.

Ramsey NB, Andersen OS.

PLoS One. 2015 Nov 9;10(11):e0142401. doi: 10.1371/journal.pone.0142401.


Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.

Gonzalez-Ceron L, Rodriguez MH, Sandoval MA, Santillan F, Galindo-Virgen S, Betanzos AF, Rosales AF, Palomeque OL.

Malar J. 2015 Oct 30;14:426. doi: 10.1186/s12936-015-0938-2.


Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.

Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, Hofmann NE, Kinboro B, Waltmann A, Brewster J, Lorry L, Tarongka N, Samol L, Silkey M, Bassat Q, Siba PM, Schofield L, Felger I, Mueller I.

PLoS Med. 2015 Oct 27;12(10):e1001891. doi: 10.1371/journal.pmed.1001891.


Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign.

Silal SP, Little F, Barnes KI, White LJ.

Malar J. 2015 Jul 12;14:268. doi: 10.1186/s12936-015-0776-2.


A novel multiple-stage antimalarial agent that inhibits protein synthesis.

Baragaña B, Hallyburton I, Lee MC, Norcross NR, Grimaldi R, Otto TD, Proto WR, Blagborough AM, Meister S, Wirjanata G, Ruecker A, Upton LM, Abraham TS, Almeida MJ, Pradhan A, Porzelle A, Martínez MS, Bolscher JM, Woodland A, Norval S, Zuccotto F, Thomas J, Simeons F, Stojanovski L, Osuna-Cabello M, Brock PM, Churcher TS, Sala KA, Zakutansky SE, Jiménez-Díaz MB, Sanz LM, Riley J, Basak R, Campbell M, Avery VM, Sauerwein RW, Dechering KJ, Noviyanti R, Campo B, Frearson JA, Angulo-Barturen I, Ferrer-Bazaga S, Gamo FJ, Wyatt PG, Leroy D, Siegl P, Delves MJ, Kyle DE, Wittlin S, Marfurt J, Price RN, Sinden RE, Winzeler EA, Charman SA, Bebrevska L, Gray DW, Campbell S, Fairlamb AH, Willis PA, Rayner JC, Fidock DA, Read KD, Gilbert IH.

Nature. 2015 Jun 18;522(7556):315-20. doi: 10.1038/nature14451.


Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries.

Mongui A, Pérez-Llanos FJ, Yamamoto MM, Lozano M, Zambrano MM, Del Portillo P, Fernández-Becerra C, Restrepo S, Del Portillo HA, Junca H.

Malar J. 2015 Jun 4;14:233. doi: 10.1186/s12936-015-0748-6.


Modelling the potential of focal screening and treatment as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region.

Rosas-Aguirre A, Erhart A, Llanos-Cuentas A, Branch O, Berkvens D, Abatih E, Lambert P, Frasso G, Rodriguez H, Gamboa D, Sihuincha M, Rosanas-Urgell A, D'Alessandro U, Speybroeck N.

Parasit Vectors. 2015 May 7;8:261. doi: 10.1186/s13071-015-0868-4.


Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.

Huijben S, Chan BH, Read AF.

Am J Trop Med Hyg. 2015 Jun;92(6):1214-21. doi: 10.4269/ajtmh.15-0036.


The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial.

Okebe J, Bousema T, Affara M, DiTanna G, Eziefula AC, Jawara M, Nwakanma D, Amambua-Ngwa A, Van Geertruyden JP, Drakeley C, D'Alessandro U.

Trials. 2015 Mar 1;16:70. doi: 10.1186/s13063-015-0597-1.

Items per page

Supplemental Content

Support Center